[Prevalence of Candida albican serotypes in blood isolates in Chile, and first report of Candida dubliniensis candidemia]
- PMID: 15456370
[Prevalence of Candida albican serotypes in blood isolates in Chile, and first report of Candida dubliniensis candidemia]
Abstract
Our main goal was to determine the prevalence of C. albicans serotypes isolates from blood cultures and identify the presence of C. dubliniensis. We studied 47 strains identified as C. albicans by conventional methods, 28 were isolated from children and 19 from adult patients. The strains were re-identified by standard methods and phenotypic screening as xylose assimilation and growth at 42 degrees C. API ID 32C (bioMérieux) was employed with the C. dubliniensis suspected strains and confirmation was made by molecular fingerprinting using random amplified polymorphic DNA (RAPD). The C. albicans serotype was determined by agglutination with antiserum anti-antigen 6 from cell wall (Candida Check, Iatron Inc., Japan) and the in vitro susceptibilities were evaluated by a microdilution method. From 47 strains, 46 were confirmed as C. albicans, 31 of them (67%) were serotype A. Adult patients presented a high prevalence of serotype A (95%) and children presented a frequency of 52% of the serotype B (p<0.05). We confirmed the identification of C. dubliniensis in one strain isolated from an infant. All serotype B strains were susceptible to fluconazole, itraconazole and amphotericin B. On the other hand, 3% and 6% of serotype A strains were "susceptible dose dependent" to fluconazole and itraconazole, respectively. C. albicans serotype A was predominant in adult candidemia and its distribution was homogenous in children patients. All strains were highly susceptible to antifungals. We report here the first case of C. dubliniensis candidemia in South America.
Similar articles
-
[Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].Mikrobiyol Bul. 2005 Apr;39(2):199-204. Mikrobiyol Bul. 2005. PMID: 16128031 Turkish.
-
[Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].Mikrobiyol Bul. 2011 Apr;45(2):306-17. Mikrobiyol Bul. 2011. PMID: 21644074 Turkish.
-
New PCR primer pairs specific for Candida dubliniensis and detection of the fungi from the Candida albicans clinical isolates in Japan.Clin Lab. 2000;46(1-2):33-40. Clin Lab. 2000. PMID: 10745979
-
[Identification of Candida dubliniensis strains using heat tolerance tests, morphological characteristics and molecular methods].Mikrobiyol Bul. 2003 Jan;37(1):49-57. Mikrobiyol Bul. 2003. PMID: 12838678 Turkish.
-
Candida dubliniensis, a new fungal pathogen.J Basic Microbiol. 2002;42(3):207-27. doi: 10.1002/1521-4028(200206)42:3<207::AID-JOBM207>3.0.CO;2-C. J Basic Microbiol. 2002. PMID: 12111748 Review.
Cited by
-
Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.PLoS One. 2012;7(3):e32952. doi: 10.1371/journal.pone.0032952. Epub 2012 Mar 2. PLoS One. 2012. PMID: 22396802 Free PMC article.
-
Epidemiology, risk factors, species distribution, and antifungal susceptibility of candidemia among hospitalized patients with COVID-19.Curr Med Mycol. 2021 Dec;7(4):12-18. doi: 10.18502/cmm.7.4.8406. Curr Med Mycol. 2021. PMID: 35747736 Free PMC article.
-
Candida dubliniensis: epidemiology and phenotypic methods for identification.Mycopathologia. 2010 Jun;169(6):431-43. doi: 10.1007/s11046-010-9286-5. Epub 2010 Feb 21. Mycopathologia. 2010. PMID: 20490751 Review.
-
Hand Carriage of Yeast in Student of Medicine, Nursing, and Medical Laboratory Science: Impact of Infection Control Measures.Microorganisms. 2024 Sep 19;12(9):1907. doi: 10.3390/microorganisms12091907. Microorganisms. 2024. PMID: 39338580 Free PMC article.
-
Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods.Mycopathologia. 2009 Jan;167(1):19-24. doi: 10.1007/s11046-008-9145-9. Epub 2008 Jul 12. Mycopathologia. 2009. PMID: 18622716